A document, vital for people having Glucose-6-phosphate dehydrogenase deficiency (favism) is available. The link is https://www.epicentro.iss.it/coronavirus/pdf/en-report-covid-19-14-2020.pdf . In this document it is told that "Chloroquine and hydroxychloroquine currently applied to COVID-19 patients should be avoided in those with severe G6PD deficiency as they could trigger a hemolytic crisis in the patient". Other very important references are also given. Besides Chloroquine and hydroxychloroquine, Primaquine and 8-Aminoquinolines are considered.

Favism, that is G6PD deficiency, and drugs for Covid-19 / Sparavigna, Amelia Carolina. - ELETTRONICO. - (2020). [10.5281/zenodo.3831384]

Favism, that is G6PD deficiency, and drugs for Covid-19

Amelia Carolina Sparavigna
2020

Abstract

A document, vital for people having Glucose-6-phosphate dehydrogenase deficiency (favism) is available. The link is https://www.epicentro.iss.it/coronavirus/pdf/en-report-covid-19-14-2020.pdf . In this document it is told that "Chloroquine and hydroxychloroquine currently applied to COVID-19 patients should be avoided in those with severe G6PD deficiency as they could trigger a hemolytic crisis in the patient". Other very important references are also given. Besides Chloroquine and hydroxychloroquine, Primaquine and 8-Aminoquinolines are considered.
2020
Favism, that is G6PD deficiency, and drugs for Covid-19 / Sparavigna, Amelia Carolina. - ELETTRONICO. - (2020). [10.5281/zenodo.3831384]
File in questo prodotto:
File Dimensione Formato  
favism1.pdf

accesso aperto

Tipologia: 2a Post-print versione editoriale / Version of Record
Licenza: Creative commons
Dimensione 80.85 kB
Formato Adobe PDF
80.85 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11583/2826112